Live tape
Top 8, mentions 7d11,571SPCX2,368 mentions▲ +0.08TSLA1,888 mentions▲ +0.05META1,807 mentions▲ +0.05GOOGL1,734 mentions▲ +0.02NFLX1,030 mentions▲ +0.03QQQ971 mentions▲ +0.05NVDA916 mentions▲ +0.07AMZN857 mentions▲ +0.07

Equity · Healthcare

IART

NASDAQ

Integra LifeSciences Holdings (IART)

$16.64 −2.12% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 31, 2026
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for IART to draw a line in its place.

Track this symbol on TradingView TradingView chart · our licensed closes: 5 sessions, 27 Jul – 31 Jul 2026
Market cap $1.3B
52-week range $8.89 – $20
Avg volume 272.3K

as of Jul 31, 2026

Integra LifeSciences Holdings (IART) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 1 Sep 2026

In the 90 days to 23 Oct 2026, no Integra LifeSciences Holdings insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Sep 2026 Veillon-Berteloot Chantal EVP & CHRO Tax withheld 1,455 $24K

Integra LifeSciences Holdings (IART) reported financials

SEC EDGAR XBRL SEC EDGAR

Integra LifeSciences Holdings reported revenue of $1.6B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$516.5M.

Figure Reported Period
Revenue $1.6B 31 Dec 2025 fiscal year
Net income −$516.5M 31 Dec 2025 fiscal year
Diluted EPS −$6.74 31 Dec 2025 fiscal year
Total assets $3.6B 30 Jun 2026 at period end
Total equity $1.0B 30 Jun 2026 at period end

Integra LifeSciences Holdings (IART) earnings

SEC EDGAR

Integra LifeSciences Holdings last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.06; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.06 —
31 Mar 2026 Q1 2026 −$0.06 —
31 Dec 2025 FY 2025 −$6.74 —
30 Sep 2025 Q3 2025 −$0.07 —
30 Jun 2025 Q2 2025 −$6.31 —
31 Mar 2025 Q1 2025 −$0.33 —
31 Dec 2024 FY 2024 −$0.09 —
30 Sep 2024 Q3 2024 −$0.14 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Integra LifeSciences Holdings (IART) institutional holders (13F)

SEC Form 13F SEC EDGAR

7 of the 45 institutional funds we track reported a Integra LifeSciences Holdings position for the quarter ended 30 Jun 2026 — a combined $60.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +131.2% shares 1,439,747 $25.9M
Balyasny Asset Management Held (±25%) −7.7% shares 640,666 $11.5M
D. E. Shaw & Co. Added +30.2% shares 507,252 $9.1M
Marshall Wace Added +101.6% shares 349,737 $6.3M
AQR Capital Management Added +90.4% shares 258,159 $4.6M
Two Sigma Investments Held (±25%) −13.0% shares 184,955 $3.3M
Renaissance Technologies New position 10,500 $189K
Citadel Advisors Exited
Maverick Capital Exited

Integra LifeSciences Holdings (IART) fails-to-deliver

SEC CNS data SEC

On 28 Sep 2026, 12,234 shares of Integra LifeSciences Holdings failed to deliver (about $197K).

Settlement date Shares failed Notional % of shares out
28 Sep 2026 12,234 $197K 0.016%
22 Sep 2026 2,883 $45K 0.004%
17 Sep 2026 4,242 $68K 0.005%
08 Sep 2026 374 $6K <0.001%

Congressional trades in Integra LifeSciences Holdings (IART)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Integra LifeSciences Holdings is a sale by Josh Gottheimer (house, NJ), dated 18 Jun 2024.

Date Member Type Amount
18 Jun 2024 filed 09 Jul 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
16 Oct 2023 filed 11 Nov 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
15 Sep 2023 filed 15 Oct 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
13 Jun 2023 filed 11 Jul 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
16 Oct 2020 filed 05 Nov 2020 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
03 Feb 2020 filed 16 Mar 2020 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K

Integra LifeSciences Holdings (IART): frequently asked questions

From live data

Have Integra LifeSciences Holdings insiders bought or sold shares recently?

In the 90 days to 23 Oct 2026, no Integra LifeSciences Holdings insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

How many institutions hold Integra LifeSciences Holdings?

7 of the 45 institutional funds we track reported a Integra LifeSciences Holdings position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Integra LifeSciences Holdings had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Integra LifeSciences Holdings is dated 28 Sep 2026, when 12,234 shares failed to deliver.

When did Integra LifeSciences Holdings last report earnings?

Integra LifeSciences Holdings last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.06; no next date is announced in SEC filings yet.

What exchange is Integra LifeSciences Holdings listed on?

Integra LifeSciences Holdings trades on NASDAQ under the ticker IART.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings